FACE

Chiesi Global Rare Diseases Makes Debut in the Endocrinology Landscape with Multiple Presentations at the Endocrine Society’s ENDO 2024 Meeting

Retrieved on: 
Mittwoch, Mai 22, 2024
ENDO, Abstract, MACRO, Barrow Neurological Institute, University, Capsule, Safety, FRCP, Neurosurgery, Endocrine system, University of Arizona, FACE, Post hoc analysis, Lipodystrophy, Pharmaceutical industry

BOSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, today announced that three abstracts have been accepted for presentation at the Endocrine Society’s ENDO 2024 Meeting to be held June 1-4, 2024, in Boston, Massachusetts.

Key Points: 
  • BOSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, today announced that three abstracts have been accepted for presentation at the Endocrine Society’s ENDO 2024 Meeting to be held June 1-4, 2024, in Boston, Massachusetts.
  • Attendees can visit Chiesi Global Rare Diseases product booth #526 and the medical booth #428.
  • Poster presentations include the latest data from the Chiesi Management of Acromegaly (MACRO) registry and a presentation on the Lipodystrophy Severity Scoring tool to assess the disease burden in lipodystrophy.
  • To register for ENDO 2024 and view the full meeting schedule, visit the Endocrine Society’s website here .

Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member

Retrieved on: 
Mittwoch, Mai 15, 2024
Patient, Risk, Amgen, Drug, Diabetes, University, Drug development, Metabolic bone disease, Fracture, FACP, Osteoporosis, Denosumab, Thomas Jefferson University, Physician, Internal medicine, Metabolism, Roivant Sciences, American College, Eli Lilly, FACE, Thomas Jefferson University Hospital

JERUSALEM, May 15, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”), a leader in the development of orally delivered peptides and small therapeutic proteins, today announced the appointment of Rachel B Wagman, MD, FACE, FACP, as Key Clinical Advisor and Member of its Scientific Advisory Board.

Key Points: 
  • JERUSALEM, May 15, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”), a leader in the development of orally delivered peptides and small therapeutic proteins, today announced the appointment of Rachel B Wagman, MD, FACE, FACP, as Key Clinical Advisor and Member of its Scientific Advisory Board.
  • Dr. Wagman brings more than 20 years of metabolic bone disease and women’s health research and drug development experience to Entera.
  • She has successfully advanced the development of five molecules, including the osteoporosis products teriparatide (Forteo®), denosumab (Prolia®) and romosozumab (Evenity®) through clinical development, registration, and lifecycle management.
  • We are extremely excited to welcome Rachel to Entera,” said Miranda Toledano, CEO of Entera.

Pilot program improves well-being of families during advanced care planning

Retrieved on: 
Freitag, Mai 3, 2024
Steps, ACP, Patient, Aircraft pilot, Sadness, Health, FACE, Research, Emotion, Senior counsel, Caregiver, Epilepsy, Family, Child, Diagnosis, RCT, Anxiety, Translation, Nursing

Called FACE Rare (FAmily CEntered Pediatric Advance Care Planning Intervention for Rare Diseases), the counseling tools were found to be safe, effective and increased feelings of peace among families in this underserved population.

Key Points: 
  • Called FACE Rare (FAmily CEntered Pediatric Advance Care Planning Intervention for Rare Diseases), the counseling tools were found to be safe, effective and increased feelings of peace among families in this underserved population.
  • In pediatrics, these diseases often require constant caregiving and require families to face the cruel reality that the diagnosis may be life-limiting.
  • In such cases, clinical teams often decide that conversations about advanced care planning (ACP) are needed.
  • They appreciated that they participated in the program and had the space to consider these difficult questions.”
    Read the full study, “Advance Care Planning for Children with Rare Diseases: A Pilot RCT,” in Pediatrics .

BeatStars Launches New Service to Help Creators Negotiate With Labels and Get Paid Faster

Retrieved on: 
Mittwoch, März 27, 2024
D4VD, Lil Baby, BeatStars, CRA, SoundExchange, Music, Intellectual property, Come See Me, Romantic Homicide, FACE

AUSTIN, Texas, March 27, 2024 (GLOBE NEWSWIRE) -- Today, BeatStars is disrupting the music industry once again by making the clearance of intellectual property rights more streamlined, affordable, and efficient with the announcement of the Creator Rights Agency. The Creator Rights Agency is an end-to-end service that allows creators to get data-driven recommendations from experts for licensing, protecting, and getting paid for their intellectual property. The CRA consolidates management, legal, and accounting services needed by creators in today’s music industry, charging a 10% commission only on the deals that are successfully negotiated by the CRA. This allows creators to retain more of their hard earned revenue, lower their costs related to closing deals, and provides creators with the ability to build a solid team - no matter the stage in their career. Creators have the flexibility to retain the services of the CRA on a non-exclusive and deal by deal basis.

Key Points: 
  • The Creator Rights Agency is an end-to-end service that allows creators to get data-driven recommendations from experts for licensing, protecting, and getting paid for their intellectual property.
  • The CRA’s state of the art portal and technology allows creators to submit requests directly to the CRA team of experts.
  • These experts use data to help creators negotiate deals, execute final agreements, receive up-front fees, and collect any backend royalties owed to them from artists, labels, and even SoundExchange.
  • This is just one more way that BeatStars stands out as easy, comprehensive, and trusted by music creators worldwide.”

Global Medical Aesthetics Market, 2023-2035: Dominance of Minimally Invasive Procedures - North America Leads, Asia-Pacific Shows Promise - ResearchAndMarkets.com

Retrieved on: 
Freitag, April 5, 2024
Other Consumer, Medical Devices, Surgery, Women, LGBTQ+, Men, Consumer, Health, Cosmetics, Retail, Migraine, Type, Medical tourism, Elective surgery, COVID-19, Bariatric surgery, Hospital, Dermatology, IPL, Ageing, Breast, Cellulite, Safety, Market, Physician, FACE, Practitioner

The market report highlights the efforts of medical aesthetics companies engaged in this growing segment of the cosmetic industry.

Key Points: 
  • The market report highlights the efforts of medical aesthetics companies engaged in this growing segment of the cosmetic industry.
  • Presently, more than 200 medical aesthetics companies are engaged in offering various products and devices to fulfill aesthetic requirements of clients.
  • Additionally, medical aesthetic companies offer all types of invasive, non invasive and minimally invasive solutions to address the requirements of all end users, such as hospitals, medical aesthetic clinic and individuals in home care settings.
  • North America leads the medical aesthetics market, driven by advanced solutions, established companies, and high demand for cosmetic procedures.

A Refreshing Perspective About the Importance of "Abiding" in Jesus

Retrieved on: 
Donnerstag, April 4, 2024
Amazon, Salem Media Group, Parable, Word, Lord, Fruit, Multimedia, Xulon Press, Imperial Noble Consort, Teaching, FACE

SUGAR LAND, Texas, April 4, 2024 /PRNewswire-PRWeb/ -- Author Larry Lee provides much-needed spiritual growth in Abide in Me, and I in You: Abide in the Vine ($10.99, paperback, 9781662873447; $4.99, e-book, 9781662873454).

Key Points: 
  • I was inspired to write this book for those who are hungry and hurting, to exhort God's people to PRAY and STUDY, SEEK GOD'S FACE.
  • As Lee explains, the word "abide" means "to consistently stay in a given place."
  • Born and raised in New Orleans, Louisiana, Larry Lee was started his journey with the Lord at only eight years old.
  • Abide in Me, and I in You: Abide in the Vine is available online through xulonpress.com/bookstore, amazon.com, and barnesandnoble.com.

OneSkin Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024

Retrieved on: 
Dienstag, März 19, 2024
SHIELD, Editorial, Culture, Organization, Antioxidant, FACE, EYE, Entrepreneurship, MIC, Journal of Cosmetic Dermatology, SAN, Journal, Research, AI, Hope, Doctor of Philosophy, Ageing, Human, Taco Bell, ITunes, Skin, Most, Fast, Nature Portfolio

SAN FRANCISCO, March 19, 2024 /PRNewswire-PRWeb/ -- OneSkin has been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2024.

Key Points: 
  • The best-in-class biotech skin health brand joins the ranks of Nvidia, YouTube, Taco Bell, and more
    SAN FRANCISCO, March 19, 2024 /PRNewswire-PRWeb/ -- OneSkin has been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2024.
  • Alongside the World's 50 Most Innovative Companies, Fast Company recognizes 606 organizations across 58 sectors and regions.
  • ( Zonari, et al., Journal of Cosmetic Dermatology, 2024 )
    The World's Most Innovative Companies stands as Fast Company's hallmark franchise and one of its most anticipated editorial efforts of the year.
  • Fast Company's Most Innovative Companies package is available online , as well as in-app form via iTunes, and on newsstands beginning March 26.

Galderma Announces Record 2023 Net Sales of Over 4 B USD and Significant Core EBITDA Margin Expansion

Retrieved on: 
Donnerstag, Februar 29, 2024
Research, Clinical Trials, Biotechnology, General Health, Pharmaceutical, Health, Cosmetics, Retail, Science, Other Science, Adapalene, Education, Investment, Growth, Calcineurin, Skin, Database, STAR, FY, Aesthetics, Acne, Sculptra, Prurigo nodularis, Defense, FACE, European Medicines Agency, Council, Congress, Pimple, GAIN, Atopic dermatitis, Sleep, ESG, Benzoyl peroxide, George Washington University, American Academy, Marketing, Health Canada, Core, Patient satisfaction, FDA, Quality of life, Ageing, Food, IL-31, Risk, AAD, Patient, Restylane, Pharmaceutical industry

2023 margin expansion was driven by gains from premiumization, structural cost savings, and operating expenses leverage, partially offset by nemolizumab investments.

Key Points: 
  • 2023 margin expansion was driven by gains from premiumization, structural cost savings, and operating expenses leverage, partially offset by nemolizumab investments.
  • On 26 June 2023, Galderma announced a private placement of approximately 1 B USD from a group consisting of current shareholders, new investors, as well as management.
  • Cetaphil, with over 75 years of heritage in sensitive skincare, surpassed a record 1 B USD in net sales in 2023.
  • In 2023, Galderma further consolidated its ESG profile by rolling out a dedicated executive-level ESG oversight and instituting the ESG Council.

The American Diabetes Association Announces the 2024 National Scientific and Health Care Achievement Award Winners

Retrieved on: 
Mittwoch, März 6, 2024
Reward, Bachelor of Science, Nursing, Royal College of Pathologists, Doctor of Philosophy, Pregnancy, University, FRCP, CUPS, Social media, American Diabetes Association, Doctor of Science, MB, FESC, Lois Jovanovic, FACP, FACE, FACC, MRCP, Book, Physician, Female, Doctor of Pharmacy, Life, Learning, Prognosis, Prediabetes, Insulin resistance, Lond, Research, FAHA, Interest, Patient, Causality, Public

ARLINGTON, Va., March 6, 2024 /PRNewswire/ -- The American Diabetes Association® is pleased to announce this year's National Scientific and Health Care Achievement Award recipients.

Key Points: 
  • ARLINGTON, Va., March 6, 2024 /PRNewswire/ -- The American Diabetes Association® is pleased to announce this year's National Scientific and Health Care Achievement Award recipients.
  • The awards honor academics, health care providers, and educators who have contributed to substantial advances in diabetes care and research.
  • ), FMedSci is the recipient of the 2024 Banting Medal for Scientific Achievement, which recognizes significant long-term contributions to the understanding, treatment, or prevention of diabetes.
  • Parker, PhD is the recipient of the 2024 Outstanding Scientific Achievement Award, which recognizes research in diabetes that demonstrates particular independence of thought and originality.

Interac partners with FACE, Launching Interactive Mapping Tool to Boost Visibility of Black-Owned Businesses Across Canada

Retrieved on: 
Dienstag, Februar 20, 2024
SMB, Black Canadians, Education, Entrepreneurship, Federation, Small business, Interac, FACE, Organization, Map, Consciousness, Heart, Mindfulness, Research, Environment, Partnership

The interactive map will also be beneficial for large-scale business owners looking to diversify their supply chains.

Key Points: 
  • The interactive map will also be beneficial for large-scale business owners looking to diversify their supply chains.
  • This tool is part of a new three-year sponsorship with FACE, a Black-led non-profit organization aimed at accelerating wealth creation for the Black community in Canada.
  • "We are excited to embark on this transformative partnership with Interac," said Tiffany Callender, Co-Founder and Chief Executive Officer of FACE.
  • Together, we aspire to empower and uplift the vibrant community of Black entrepreneurs, promoting inclusivity and driving positive change across Canada."